$40 Million High-Risk Stem Cell Research; IOM and CIRM on Engaging Biotech Biz
Directors of the California stem cell agency this Wednesday will be asked to approve initiation of a $40 million, high-risk research program aimed at filling “key gaps” in knowledge about human stem cell behavior.
The concept plan for the round – called Basic Biology V – will come up for approval at the governing board meeting in Los Angeles. Pre-applic…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.